Protalix
Sector: Healthcare & Life Sciences
About Protalix
Biopharmaceutical company focused on the development, production, and commercialization of innovative medicines for patients living with rare diseases. Delivering recombinant therapeutic proteins with clinically improved profiles.(NYSE:PLX, TASE:PLX)i
Products
ELFABRIO; ELELYSO® (Gaucher Disease)
For the treatment of adult patients with Fabry Disease and for the treatment of Gaucher Disease. Protein therapeutics through proprietary, commercial-scale ProCellEx® plant cell-based protein expression system, as well as chemical and genetic modification capabilities, including PEGylation.